BRPI0819342A2 - Produto medicinal ou líquido nutricional administrável oralmente, produto hidratante líquido administrável oralmente, produto alimentício de textura modificada, assim como o uso de ditos produtos. - Google Patents

Produto medicinal ou líquido nutricional administrável oralmente, produto hidratante líquido administrável oralmente, produto alimentício de textura modificada, assim como o uso de ditos produtos.

Info

Publication number
BRPI0819342A2
BRPI0819342A2 BRPI0819342-8A BRPI0819342A BRPI0819342A2 BR PI0819342 A2 BRPI0819342 A2 BR PI0819342A2 BR PI0819342 A BRPI0819342 A BR PI0819342A BR PI0819342 A2 BRPI0819342 A2 BR PI0819342A2
Authority
BR
Brazil
Prior art keywords
product
orally administrable
liquid
products
well
Prior art date
Application number
BRPI0819342-8A
Other languages
English (en)
Inventor
Kevin Burke Miller
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40139229&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0819342(A2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BRPI0819342A2 publication Critical patent/BRPI0819342A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
    • A23L2/52—Adding ingredients
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/164—Amides, e.g. hydroxamic acids of a carboxylic acid with an aminoalcohol, e.g. ceramides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Neurology (AREA)
  • Mycology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Botany (AREA)
  • Obesity (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Psychology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Tea And Coffee (AREA)
  • Dairy Products (AREA)
BRPI0819342-8A 2007-11-19 2008-10-07 Produto medicinal ou líquido nutricional administrável oralmente, produto hidratante líquido administrável oralmente, produto alimentício de textura modificada, assim como o uso de ditos produtos. BRPI0819342A2 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US98893007P 2007-11-19 2007-11-19
US2289908P 2008-01-23 2008-01-23
PCT/US2008/079044 WO2009067296A1 (en) 2007-11-19 2008-10-07 Treatment of oral pharyngeal dysphagia

Publications (1)

Publication Number Publication Date
BRPI0819342A2 true BRPI0819342A2 (pt) 2015-05-19

Family

ID=40139229

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0819342-8A BRPI0819342A2 (pt) 2007-11-19 2008-10-07 Produto medicinal ou líquido nutricional administrável oralmente, produto hidratante líquido administrável oralmente, produto alimentício de textura modificada, assim como o uso de ditos produtos.

Country Status (17)

Country Link
US (1) US8871281B2 (pt)
EP (2) EP2222289B2 (pt)
JP (2) JP2011504172A (pt)
CN (1) CN101848709A (pt)
AR (1) AR069356A1 (pt)
AU (1) AU2008326640C1 (pt)
BR (1) BRPI0819342A2 (pt)
CA (1) CA2705836C (pt)
CL (1) CL2008003438A1 (pt)
DK (1) DK2222289T3 (pt)
MX (1) MX2010005465A (pt)
PT (1) PT2222289E (pt)
RU (2) RU2481829C2 (pt)
SG (1) SG188167A1 (pt)
TW (1) TWI426899B (pt)
WO (1) WO2009067296A1 (pt)
ZA (1) ZA201004333B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2222289T3 (da) 2007-11-19 2013-10-07 Nestec Sa Behandling af oral pharyngeal dysphagi
CN108902893B (zh) 2013-02-08 2022-02-25 通用磨坊公司 低钠食品
US9801833B2 (en) 2013-07-22 2017-10-31 Nestec S.A. Compositions and methods using tiglic aldehyde
WO2017179225A1 (ja) * 2016-04-13 2017-10-19 味の素株式会社 加齢に伴う身体機能低下もしくは身体機能障害、または加齢に伴う精神機能低下もしくは精神機能障害の抑制または改善用組成物
CN108142940B (zh) * 2018-02-05 2021-05-14 中山大学附属第三医院（中山大学肝脏病医院） 一种促吞咽软片及其制备方法
JP7519359B2 (ja) * 2018-12-24 2024-07-19 ソレント・セラピューティクス・インコーポレイテッド レシニフェラトキシンを投与することによってパーキンソン病を処置するための方法
RU2714177C1 (ru) * 2019-07-23 2020-02-12 Федеральное Государственное Бюджетное Научное Учреждение "Федеральный Научно-Клинический Центр Реаниматологии И Реабилитологии" (Фнкц Рр) Способ лечения крикофарингеальной недостаточности и восстановления функции глотания
EP4181691A1 (en) * 2020-07-15 2023-05-24 Société des Produits Nestlé S.A. Compositions to promote swallowing safety and efficiency

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH07274915A (ja) * 1994-03-31 1995-10-24 Taiyo Kagaku Co Ltd 柔軟性容器入りゼリー様飲料
JP3345744B2 (ja) 1998-03-04 2002-11-18 森永製菓株式会社 エステル結合を有する新規なカプサイシノイド様物質
US20020019444A1 (en) * 2000-05-08 2002-02-14 Edward Hogestatt Anandamide and structurally related lipids as vanilloid receptor modulators
US7638150B2 (en) * 2002-08-02 2009-12-29 Simply Thick Llp Process for preparing concentrate thickener compositions
US20030082249A1 (en) * 2001-10-26 2003-05-01 Ovation Pharmaceuticals Compositions containing capsaicin and its derivatives, and their use in treating mucositis
GB0221157D0 (en) 2002-09-12 2002-10-23 Glaxo Group Ltd Novel treatment
CN100431553C (zh) * 2002-12-26 2008-11-12 株式会社山田养蜂场本社 改善咽下障碍用组合物
WO2004069179A2 (en) 2003-01-31 2004-08-19 Simply Thick Llc Improved thickened beverages for dysphagia
US7943166B2 (en) * 2003-04-10 2011-05-17 Neurogesx, Inc. Methods and compositions for administration of TRPV1 agonists
US20060182825A1 (en) 2005-02-11 2006-08-17 The Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Methods and compounds for the treatment of obesity and obesity-related disorders
JP4526472B2 (ja) 2005-12-02 2010-08-18 仁敬 越久 嚥下障害治療装置
CA2641950A1 (en) * 2006-02-10 2007-08-23 Mannatech, Inc. All natural multivitamin and multimineral dietary supplement formulations for enhanced absorption and biological utilization
ES2429288T3 (es) * 2006-04-24 2013-11-14 Ajinomoto Co., Inc. Agente para la mejora de la disfagia, y composición farmacéutica o alimenticia que comprende el mismo
DK2222289T3 (da) 2007-11-19 2013-10-07 Nestec Sa Behandling af oral pharyngeal dysphagi

Also Published As

Publication number Publication date
CA2705836C (en) 2014-06-10
MX2010005465A (es) 2010-06-02
CA2705836A1 (en) 2009-05-28
DK2222289T3 (da) 2013-10-07
EP2222289A1 (en) 2010-09-01
RU2013103032A (ru) 2014-07-27
RU2010125285A (ru) 2011-12-27
EP2222289B1 (en) 2013-08-28
US8871281B2 (en) 2014-10-28
WO2009067296A1 (en) 2009-05-28
PT2222289E (pt) 2013-09-30
EP2578213A1 (en) 2013-04-10
CL2008003438A1 (es) 2010-01-11
CN101848709A (zh) 2010-09-29
AU2008326640A1 (en) 2009-05-28
SG188167A1 (en) 2013-03-28
RU2481829C2 (ru) 2013-05-20
JP2011504172A (ja) 2011-02-03
ZA201004333B (en) 2011-12-28
AR069356A1 (es) 2010-01-13
TW200934479A (en) 2009-08-16
JP2013056893A (ja) 2013-03-28
AU2008326640C1 (en) 2013-07-04
HK1142010A1 (en) 2010-11-26
AU2008326640B2 (en) 2012-08-23
TWI426899B (zh) 2014-02-21
US20110028382A1 (en) 2011-02-03
EP2222289B2 (en) 2025-05-14

Similar Documents

Publication Publication Date Title
BRPI0918139A2 (pt) composição, alimento medicinal ou funcional, suplemento alimentar ou dietético para tratamento de distúrbios de desenvolvimento pervasivos com terapêuticos redox-ativos e uso
BRPI0811824A2 (pt) "produto alimentício fluído ou semi-fluido estável, método para a produção de produtos alimentícios fluidos ou semi-fluidos, preparação intermediária, uso de uma preparação intermediária, método para a produção de uma preparação intermediária e usos não terapêuticos do produto alimentício"
PH12013501292A1 (en) Nutritional products comprising calcium beta-hydroxy-beta methylbutyrate and conjugated linoleic acid
IT1391454B1 (it) Contenitore per prodotti fluidi, particolarmente farmaceutici, cosmetici, alimentari o simili
BRPI0814981A2 (pt) Produto alimentício líquido que pode ser batido, produto batido, e, produto pré-batido.
PL2448939T3 (pl) Pochodne 2,3-dihydro-1h-imidazo {1,2-a} pirymidyn-5-onu, ich wytwarzanie i ich zastosowanie farmaceutyczne
BR112012021455A2 (pt) formulação farmacêutica ou nutracêutica.
FR2944794B1 (fr) Procede de preparation d'oligomeres de glycoside de flavonoide et utilisation en cosmetique.
BR112012004809A2 (pt) 7,10,13-ciclohexadecatrien-16-olídeo e composição de sabor ou de fragância, fragância ou produto cosméticos, produto alimentar ou bebida ou produto de toalete compreendendo o mesmo
TH101544B (th) ช้อน
TH87366B (th) อ่างอาบน้ำ
TH109574S (th) อ่างอาบน้ำ
TH83697B (th) ผลิตภัณฑ์อาหาร
TH83688B (th) ผลิตภัณฑ์อาหาร
TH83698B (th) ผลิตภัณฑ์อาหาร
TH84313B (th) โซฟา
TH105060S (th) ภาชนะบรรจุ
TH96487S (th) เตียง
TH85249B (th) ภาชนะบรรจุ
TH101546B (th) มีด
TH84619B (th) อ่างอาบน้ำ
TH40284S1 (th) ขวด
TH110298S (th) ตัวปรับระดับของผนังกั้น
TH111116S (th) ชั้นโชว์สินค้า
TH85481B (th) ปากกา

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: A61K 31/165 (2006.01), A23L 2/52 (2006.01), A23L 3

B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL